1. Be aware of skin reactions with propylene glycol

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Deferoxamine may cause neurotoxic, cardiovascular and blood disorders

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Analysis of 6847 patients fails to show adverse ophthalmological effects with lovastatin

   Newsletter Article 31 January 2013 Pages: 2 - 2

4. Results with high dose epinephrine for heart arrest justify continued research but no immediate use

   Newsletter Article 31 January 2013 Pages: 2 - 3

5. Alteplase/streptokinase

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Amiodarone

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Amiodarone see Theophylline interaction

   Newsletter Article 31 January 2013 Pages: 3 - 3

8. Beta lactam interactions

   Newsletter Article 31 January 2013 Pages: 3 - 3

9. Bleomycin

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Captopril

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Captopril/enalapril

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Ciprofloxacin see Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Clonidine withdrawal

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Cocaine abuse

    Newsletter Article 31 January 2013 Pages: 4 - 4

16. Corticosteroids

    Newsletter Article 31 January 2013 Pages: 4 - 4

17. Cyclophosphamide

    Newsletter Article 31 January 2013 Pages: 4 - 4

18. Cyclophosphamide see Prednisone/cyclophosphamide

    Newsletter Article 31 January 2013 Pages: 4 - 4

19. Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Dextran 70

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Diltiazem

    Newsletter Article 31 January 2013 Pages: 5 - 5

22. Enalapril see Captopril/enalapril

    Newsletter Article 31 January 2013 Pages: 5 - 5

23. Epinephrine

    Newsletter Article 31 January 2013 Pages: 5 - 6

24. Epirubicin

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Erythromycin

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Gemfibrozil interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Glibenclamide see Gemfibrozil interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

28. Granulocyte-macrophage colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 6 - 6

29. Haloperidol

    Newsletter Article 31 January 2013 Pages: 6 - 6

30. Hydrocortisone

    Newsletter Article 31 January 2013 Pages: 6 - 6

31. Iron dextran

    Newsletter Article 31 January 2013 Pages: 6 - 6

32. Lovastatin

    Newsletter Article 31 January 2013 Pages: 6 - 7

33. Lovastatin/simvastatin

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Methamphetamine abuse

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Methoxsalen +; ultraviolet A light

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Midazolam withdrawal

    Newsletter Article 31 January 2013 Pages: 7 - 7

37. Pefloxacin

    Newsletter Article 31 January 2013 Pages: 7 - 7

38. Pentamidine

    Newsletter Article 31 January 2013 Pages: 7 - 7

39. Phenobarbital see Beta lactam interactions

    Newsletter Article 31 January 2013 Pages: 7 - 7

40. Prednisone/cyclophosphamide

    Newsletter Article 31 January 2013 Pages: 7 - 8

41. Psoralens +; ultraviolet A light

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Pyrazinamide

    Newsletter Article 31 January 2013 Pages: 8 - 8

43. Simvastatin see Lovastatin/simvastatin

    Newsletter Article 31 January 2013 Pages: 8 - 8

44. Streptokinase see Alteplase/streptokinase

    Newsletter Article 31 January 2013 Pages: 8 - 8

45. Theophylline interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

46. Valproic acid

    Newsletter Article 31 January 2013 Pages: 8 - 8